Rule30

Aiomics is the AI co-pilot for healthcare providers, capturing and structuring patient information to improve documentation and compliance, allowing physicians to focus more on patient care.

Archer automates payouts and incentives based on real business activities and integrates with existing tools. It's designed for various teams to automate payouts for deals, milestones, and support outcomes.

Clera is a talent agent for people looking for their next startup role, facilitating introductions between candidates and startup companies based on their profiles and preferences.

Emerge is a company developing next-generation technology and devices. Their storefront is currently operational, showcasing their latest offerings.

Helping people age well.

Gyre Energy provides AI-driven solutions for optimizing energy use in cooling systems, particularly for cold storage, data centers, and building portfolios, aiming to reduce costs and emissions.

Helix is building the DNA of the new Internet, providing a privacy-first identity layer that authenticates users and routes humans and bots in real time.

Jiro offers flexible corporate loans designed to help businesses achieve their growth goals or secure short-term capital. They provide a fast application process, individual interest rates, and no prepayment fees, with funds disbursed within 24 hours.

Kiin Bio is an AI-powered drug discovery platform that accelerates research with Virtual Scientists, integrating over 100 specialized tools into one intelligent workflow to enhance drug discovery processes.

Lemrock enables brands to connect their product catalog to LLMs and sell directly within agent-driven conversational environments, facilitating AI-native commerce experiences.

AI-native document platform purpose-built for human-agent collaboration, designed for high-growth teams with agents in the loop.

Early-stage batch accelerator turning tiny MVPs into companies via 400+ startups per batch, intense peer-pressure learning, founder-character screening, and founder-first support that reduces career risk. YC pioneered the modern batch-based accelerator model in 2005, systematically transforming tiny MVPs into venture-scale companies at industrial scale with 400+ startups per batch and a portfolio exceeding 4,000 companies, achieving unusually high success rates where ~4.5-5.5% become unicorns compared to ~2.5% for other venture-backed startups.

Thrive Capital operates with a deliberately low-profile, secretive brand and attribution-free team model while making a small number of very large, high-conviction bets and stepping in as an anchor investor during market stress. The firm combines early-stage investing with multi-billion-dollar growth rounds from the same platform while maintaining a small, elite partnership and hybrid identity as both investor and operator through company-building efforts.

Early-stage boutique that publicly rebooted after admitting a lost decade, offering an institutionalized Fellows talent pipeline funneling top students into breakout startups. Kleiner Perkins deliberately transformed from a sprawling, personality-driven platform into a tighter early-stage boutique after 2018, openly acknowledging a 'lost decade' and marketing their turnaround as a core part of their brand story. The firm built one of the industry's most structured talent pipelines through their Kleiner Perkins Fellows program, which provides a systematic route for top students into breakout startups and comes with KP-sponsored seed capital.

Invests globally in exceptional B2B/SaaS companies and prioritizes inclusive investment regardless of founders race, national origin, or gender.